Skip to content
MedsAcross

Brand family

Xerava

Eravacycline · Tetraphase Pharmaceuticals
United States
Presentations
2
Markets
1

Xerava is a brand of Eravacycline marketed by Tetraphase Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Eravacycline
Brand owner
Tetraphase Pharmaceuticals
Registered in
United States
Strengths and forms
100 mg powder for injection, 50 mg powder for injection

All presentations

MedicineManufacturerRegisterAvailability
Xerava 100 mg powder for injectionIntravenous Cold chainTetraphase PharmaceuticalsUS FDAAvailable on request
Xerava 50 mg powder for injectionIntravenous Cold chainTetraphase PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Xerava

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.